Understanding life and death decisions in human leukaemias.

about

Understanding life and death decisions in human leukaemias.

Item

http://www.wikidata.org/entity/Q55071953

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Understanding life and death decisions in human leukaemias.

@en

Understanding life and death decisions in human leukaemias.

@nl

type

Item

label

Understanding life and death decisions in human leukaemias.

@en

Understanding life and death decisions in human leukaemias.

@nl

prefLabel

Understanding life and death decisions in human leukaemias.

@en

Understanding life and death decisions in human leukaemias.

@nl

P1476

Understanding life and death decisions in human leukaemias

@en

P2093

Lawrence N Barrera

http://www.w3.org/2001/XMLSchema#string

Lyubov Zaitseva

http://www.w3.org/2001/XMLSchema#string

Niraj M Shah

http://www.w3.org/2001/XMLSchema#string

Sujitra Keadsanti

http://www.w3.org/2001/XMLSchema#string

Tianma Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

HO-1 underlies resistance of AML cells to TNF-induced apoptosis

Nrf2 regulates haematopoietic stem cell function

Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis

Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

miR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury

Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

P304

747-751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BST20140127

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David J MacEwan

Stuart A Rushworth

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25109952

http://www.w3.org/2001/XMLSchema#string

P921

leukemia